Zoetis (ZTS) Revenue (2012 - 2026)
Zoetis (ZTS) posted quarterly Revenue of $2.3 billion for Q1 2026, up 2.91% year-over-year from $2.2 billion in Q1 2025, and down 5.24% quarter-over-quarter from $2.4 billion in Q4 2025.
Zoetis (ZTS) Revenue (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Revenue for 15 consecutive years, with $2.3 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue rose 2.91% year-over-year to $2.3 billion; the TTM figure through Mar 2026 stood at $9.5 billion (up 2.64% YoY), while the FY2025 annual figure was $9.5 billion, up 2.28% from the prior year.
- Revenue retreated to $2.3 billion in Q1 2026 per ZTS's latest filing, from $2.4 billion in the prior quarter.
- Across five years, Revenue topped out at $2.5 billion in Q2 2025 and bottomed at $2.0 billion in Q1 2022.
- Historically, Revenue has averaged $2.2 billion across 5 years, with a median of $2.2 billion in 2025.
- Annual changes were most pronounced in 2024 — Revenue rose 11.02% — and 2025, when it rose 0.37%.
- Zoetis' Revenue stood at $2.0 billion in 2022, then gained by 8.48% to $2.2 billion in 2023, then rose by 4.7% to $2.3 billion in 2024, then rose by 3.02% to $2.4 billion in 2025, then decreased by 5.24% to $2.3 billion in 2026.
- Business Quant data shows ZTS's Revenue at $2.3 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 86.50 Bn | 85.53 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.71 Bn | 39.05 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 30.86 Bn | 29.18 Bn | 1.80 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.50 Bn | 22.70 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.06 Bn | 19.40 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.84 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Vireo Growth | 11.86 Bn | 11.71 Bn | 59.30 Mn | 106.20 Mn |
| 9 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 1.37 Bn |
| 10 | HUTCHMED (China) | 10.92 Bn | 9.54 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.47 Bn |
| Mar 31, 2026 | 2.26 Bn |
| Dec 31, 2025 | 2.39 Bn |
| Sep 30, 2025 | 2.40 Bn |
| Jun 30, 2025 | 2.46 Bn |
| Mar 31, 2025 | 2.20 Bn |
| Dec 31, 2024 | 2.32 Bn |
| Sep 30, 2024 | 2.39 Bn |
| Jun 30, 2024 | 2.36 Bn |
| Mar 31, 2024 | 2.19 Bn |
| Dec 31, 2023 | 2.21 Bn |
| Sep 30, 2023 | 2.15 Bn |
| Jun 30, 2023 | 2.18 Bn |
| Mar 31, 2023 | 2.00 Bn |
| Dec 31, 2022 | 2.04 Bn |
| Sep 30, 2022 | 2.00 Bn |
| Jun 30, 2022 | 2.05 Bn |
| Mar 31, 2022 | 1.99 Bn |
| Dec 31, 2021 | 1.97 Bn |
| Sep 30, 2021 | 1.99 Bn |